The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
Calcineurin inhibitor induced nephrotoxicity contributes to late allograft failure in kidney transplant patients. Evidence points towards aldosterone to play a role in the development of fibrosis in multiple o...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Line Aas Mortensen, Helle C. Thiesson, Birgitte Tougaard, Martin Egfjord, Anne Sophie Lind Fischer and Claus Bistrup Tags: Study protocol Source Type: research
More News: Bone Graft | Clinical Trials | Kidney Transplant | Kidney Transplantation | Spironolactone | Study | Transplant Surgery | Transplants | Urology & Nephrology